ROBUST: First report of phase III randomized study of lenalidomide/R‐CHOP (R2‐CHOP) vs placebo/R‐CHOP in previously untreated ABC‐type diffuse large B‐cell lymphoma. (12th June 2019)

• Record Type: Journal Article
• Authors: Vitolo, U.; Witzig, T.E.; Gascoyne, R.D.; Scott, D.W.; Zhang, Q.; Jurczak, W.; Özcan, M.; Hong, X.; Zhu, J.; Jin, J.; Belada, D.; Bergua, J.M.; Piazza, F.; Mócikova, H.; Molinari, A.L.; Yoon, D.H.; Cavallo, F.; Tani, M.; Izutsu, K.; Kato, K.; Czuczman, M.; Hersey, S.; Kilcoyne, A.; Russo, J.; Hudak, K.; Zhang, J.; Chiappella, A.; Nowakowski, G.S.
• Is Part Of: Hematological oncology. Volume 37(2019)Supplement 2
• Page Start: 36
• Page End: 37
• Publication Date: 2019-06-12
• Subjects: Hematological oncology -- Periodicals; Hematology; Medical Oncology; 616.99418005
• DOI: 10.1002/hon.5_2629
• Languages: English
• ISSNs: 0278-0232